Pharmakon Advisors, LP (“Pharmakon”) is the investment manager of the BioPharma Credit funds. Established in 2009, Pharmakon has raised a total of US$4.9 billion, principally across five private funds and a publicly traded UK Trust. BioPharma Credit PLC (ticker: BPCR.L “BPCR”) was listed on the London Stock Exchange in March 2017 and has raised a total of $1.4 billion in capital. Pharmakon has committed US$9.8 billion across 57 investments in companies in the life sciences.
Company Details
- Employees
- 12
- Founded
- 2009
- Address
- 110 E 59th St, New York,10022,united States
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- bpcruk.com
- Keywords
- Boston.
- HQ
- New York
Pharmakon Advisors, Lp Questions
Pharmakon Advisors, Lp's website is bpcruk.com
Pharmakon Advisors, Lp's LinkedIn profile is https://www.linkedin.com/company/pharmakon-advisors-lp
Pharmakon Advisors, Lp has
12 employees.
View email and phone details for 12
employees at Pharmakon Advisors, Lp.
Pharmakon Advisors, Lp's industry is
Investment Management
Pharmakon Advisors, Lp's top competitors are
Cowen Inc.,
Healthcare Royalty,
Geron Corporation,
Mts Health Partners,
Ra Capital Management,
Dri Healthcare,
Aisling Capital,
Royalty Pharma,
Fortress Investment Group,
Orbimed.
Pharmakon Advisors, Lp's categories are Investment Management
Pharmakon Advisors, Lp's founding year is 2009
